Eiger Biopharmaceutica Stock Forecast - Polynomial Regression

EIGRDelisted Stock  USD 0.74  0.03  3.90%   
The Polynomial Regression forecasted value of Eiger Biopharmaceuticals on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.62. Eiger Stock Forecast is based on your current time horizon.
  
Eiger Biopharmaceutica polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Eiger Biopharmaceuticals as well as the accuracy indicators are determined from the period prices.

Eiger Biopharmaceutica Polynomial Regression Price Forecast For the 28th of November

Given 90 days horizon, the Polynomial Regression forecasted value of Eiger Biopharmaceuticals on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.62.
Please note that although there have been many attempts to predict Eiger Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eiger Biopharmaceutica's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Eiger Biopharmaceutica Stock Forecast Pattern

Backtest Eiger BiopharmaceuticaEiger Biopharmaceutica Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Eiger Biopharmaceutica stock data series using in forecasting. Note that when a statistical model is used to represent Eiger Biopharmaceutica stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.4134
BiasArithmetic mean of the errors None
MADMean absolute deviation0.043
MAPEMean absolute percentage error0.0504
SAESum of the absolute errors2.624
A single variable polynomial regression model attempts to put a curve through the Eiger Biopharmaceutica historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Eiger Biopharmaceutica

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eiger Biopharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.740.740.74
Details
Intrinsic
Valuation
LowRealHigh
0.700.700.81
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eiger Biopharmaceutica. Your research has to be compared to or analyzed against Eiger Biopharmaceutica's peers to derive any actionable benefits. When done correctly, Eiger Biopharmaceutica's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eiger Biopharmaceuticals.

View Eiger Biopharmaceutica Related Equities

 Risk & Return  Correlation

Eiger Biopharmaceutica Market Strength Events

Market strength indicators help investors to evaluate how Eiger Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eiger Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Eiger Biopharmaceutica stock market strength indicators, traders can identify Eiger Biopharmaceuticals entry and exit signals to maximize returns.

Eiger Biopharmaceutica Risk Indicators

The analysis of Eiger Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eiger Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eiger stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Eiger Biopharmaceutica

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eiger Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eiger Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.

Moving together with Eiger Stock

  0.83PPERY Bank Mandiri PerseroPairCorr
  0.65PPERF Bank Mandiri PerseroPairCorr
  0.61BKRKF PT Bank RakyatPairCorr

Moving against Eiger Stock

  0.79BAC Bank of America Aggressive PushPairCorr
  0.75CSCO Cisco Systems Aggressive PushPairCorr
  0.66TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.65AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.65WMT Walmart Aggressive PushPairCorr
The ability to find closely correlated positions to Eiger Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eiger Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eiger Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eiger Biopharmaceuticals to buy it.
The correlation of Eiger Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eiger Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eiger Biopharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eiger Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Eiger Stock

If you are still planning to invest in Eiger Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eiger Biopharmaceutica's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets